Oxford Science Enterprises is a venture capital firm that specializes in building and investing in life sciences companies. It focuses on scientific breakthroughs and transformative technologies that have the potential to create new industries or reshape existing ones. The firm provides capital, expertise, and access to a network of scientists, entrepreneurs, and industry experts to support the growth and development of its portfolio companies.

Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund and build transformational businesses via our unique partnership with the University of Oxford, the world’s #1 research university. 

This partnership enables us to work with the brightest academic minds tackling the world’s toughest challenges and guarantees us unrivalled access to their scientific research. In collaboration with our global network of entrepreneurs and advisors, we go well beyond funding to shape and nurture these complex ideas into successful businesses. 

Actively focused on a core portfolio of around 40 companies spanning three high-growth, high-impact sectors – Life Sciences, Health Tech, Deep Tech – we adopt a flexible, long-term investment approach, recognising the path from ground-breaking research to global markets takes time and resilience.

To date, we have invested £0.6 billion in over 80 ambitious companies built on Oxford science, helping progress >50 from seed to Series A, and >20 to Series B and beyond, including 2 IPOs and 7 trade sales. 

A key player in Oxford’s entrepreneurial ecosystem, we are highly motivated to foster an environment that catalyses pioneering research and steers it to commercial success. We are committed to doing this in an inclusive and sustainable way.

COM:OXFORDSCIENCEENTERPRISES

Oxford Science Enterprises

Analysis Not Available